Botanix Pharmaceuticals Limited (ASX:BOT)
Australia
· Delayed Price · Currency is AUD 0.515
+0.010 (1.98%)
Feb 21, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Revenue
In the fiscal year ending June 30, 2024, Botanix Pharmaceuticals had annual revenue of 2.07M AUD, down -45.14%. Botanix Pharmaceuticals had revenue of 1.69M in the half year ending June 30, 2024, a decrease of -38.60%.
Revenue
2.07M
Revenue Growth
-45.14%
P/S Ratio
n/a
Revenue / Employee
188.14K
Employees
11
Market Cap
940.20M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 16.66B |
| Ansell | 3.00B |
| Mesoblast | 8.85M |
Botanix Pharmaceuticals News
- 4 weeks ago - This media company’s share price is tipped to double - The Australian Financial Review